Medical policies for providers

See the latest updates to our medical policies. 

Choose a letter to view policies by first letter.

A B C D E F G H I J K L M N O P Q R S T U V W 

J

MP197-Janus Kinase 2 (JAK 2) Gene Mutation Analysis
Janus Kinase 2(JAK 2,  JAK 2V617F) mutation analysis has been proposed as a laboratory test to aid in the diagnosis and clinical management of patients with myeloproliferative disorder.
 

Related information

Learn more about Geisinger Health Plan.

Prior authorizations

Log in to NaviNet to access and view prior authorization information.

Clinical guidelines

Clinical guidelines offer providers consistent and appropriate guidance for diagnosis and treatment of specific conditions or diseases.

Terms and conditions

View GHP’s terms and conditions.

Questions? Contact us

If you have questions or need more information, contact Geisinger Health Plan.